SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

NCT01749969 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Plasma Cell Myeloma

Interventions

DRUG: isatuximab SAR650984
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

Sanofi